Last reviewed · How we verify
polyethylene glycol plus ascorbic acid
At a glance
| Generic name | polyethylene glycol plus ascorbic acid |
|---|---|
| Sponsor | Hospital Universitario de Canarias |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures (NA)
- Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life (NA)
- Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure (PHASE3)
- Artificial Intelligence and Bowel Cleansing Quality
- Patient and Colonoscopy Cleansing Quality Agreement
- Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia
- Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma (PHASE2)
- Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: